UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 209

Sortiert nach

The clinical relevance of a chemo response assay for treatment of epithelial ovarian cancer

Gynecologic oncology, 2014-06, Vol.133, p.189-190

2014

Volltextzugriff (PDF)

Significant delay in the treatment of endometrial cancer based on race and insurance status

Gynecologic oncology, 2014-06, Vol.133, p.150-151

2014

Volltextzugriff (PDF)

A phase II evaluation of AZD6244, a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

Gynecologic oncology, 2013-07, Vol.130 (1), p.e12-e13

2013

Volltextzugriff (PDF)

A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group (GOG) study

Gynecologic oncology, 2015-05, Vol.138, p.2-2

2015

Volltextzugriff (PDF)

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study

Gynecologic oncology, 2012-03, Vol.125, p.S17-S17

2012

Volltextzugriff (PDF)

Controversies associated with cervical cytologic screening: a physician's view

American journal of clinical pathology, 2000-11, Vol.114 Suppl, p.S44-S47

Rotmensch, J

2000

Volltextzugriff (PDF)

An α-Fetoprotein-Producing Hepatoid Adenocarcinoma of the Endometrium

Gynecologic oncology, 2001-11, Vol.83 (2), p.418-421

2001

Volltextzugriff (PDF)

Intraperitoneal administration of alpha-emitting isotopes

Gynecologic oncology, 2014-06, Vol.133, p.106-106

Dewdney, S.B

2014

Volltextzugriff (PDF)

Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies

International journal of radiation oncology, biology, physics, 2002-04, Vol.52 (5), p.1330-1337

2002

Volltextzugriff (PDF)

Uterine carcinosarcoma: Immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets

Gynecologic oncology, 2007-04, Vol.105 (1), p.138-144

2007

Volltextzugriff (PDF)

Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy

International journal of radiation oncology, biology, physics, 2003-10, Vol.57 (2), p.516-521

2003

Volltextzugriff (PDF)

Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies

International journal of radiation oncology, biology, physics, 2002-12, Vol.54 (5), p.1388-1396

2002

Volltextzugriff (PDF)

Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors

Annals of oncology, 2001-12, Vol.12 (12), p.1743-1747

2001

Volltextzugriff (PDF)

Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies

International journal of radiation oncology, biology, physics, 2000-12, Vol.48 (5), p.1613-1621

2000

Volltextzugriff (PDF)

Synchronous ovarian and endometrial malignancies

American journal of clinical oncology, 2000-10, Vol.23 (5), p.521-525

2000

Volltextzugriff (PDF)

Outcome and patterns of failure in pathologic stages I–IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy

International journal of radiation oncology, biology, physics, 2003-04, Vol.55 (5), p.1272-1276

2003

Volltextzugriff (PDF)

Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients

International journal of radiation oncology, biology, physics, 2005-03, Vol.61 (4), p.1078-1086

2005

Volltextzugriff (PDF)

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

International journal of radiation oncology, biology, physics, 2001-08, Vol.50 (5), p.1145-1153

2001

Volltextzugriff (PDF)

Initial Clinical Experience with Intensity-Modulated Whole-Pelvis Radiation Therapy in Women with Gynecologic Malignancies

Gynecologic oncology, 2001-09, Vol.82 (3), p.456-463

2001

Volltextzugriff (PDF)

Radionuclide Therapy for the Treatment of Microscopic Ovarian Carcinoma: An Overview

Industrial & engineering chemistry research, 2000-09, Vol.39 (9), p.3135-3139

2000

Volltextzugriff (PDF)

Rectovaginal radiation fistula repair using an obturator fasciocutaneous thigh flap

Gynecologic oncology, 2004-08, Vol.94 (2), p.277-282

2004

Volltextzugriff (PDF)

Phase II trial of imatinib mesylate (I) in combination with docetaxel (D) in the treatment of patients (pts) with recurrent or persistent epithelial ovarian carcinoma (EOC)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e16552-e16552

2009

Volltextzugriff (PDF)

Outcome and pattern of failure in pathologic stage I–II papillary serous carcinoma of the endometrium: Implications for adjuvant radiation therapy

International journal of radiation oncology, biology, physics, 2003-11, Vol.57 (4), p.1004-1009

2003

Volltextzugriff (PDF)

Activity of docetaxel plus trabectedin in recurrent or persistent ovarian and primary peritoneal cancer: A phase II study of the Gynecologic Oncology Group (GOG)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5046-5046

2010

Volltextzugriff (PDF)

In vitro and in vivo studies on the development of the α-emitting radionuclide bismuth 212 for intraperitoneal use against microscopic ovarian carcinoma

American journal of obstetrics and gynecology, 1997-04, Vol.176 (4), p.833-841

1997

Volltextzugriff (PDF)

1 – 25 von 209

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(179)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(143)
Science & Technology
(132)
Life Sciences & Biomedicine
(131)
Female
(125)
Biological And Medical Sciences
(107)
Medical Sciences
(99)
Adult
(82)
Obstetrics & Gynecology
(71)
Middle Aged
(68)
Oncology
(57)
Gynecology. Andrology. Obstetrics
(55)
Aged
(50)
Tumors
(38)
Pregnancy
(33)
Female Genital Diseases
(29)
Male
(29)
Pharmacology. Drug Treatments
(24)
Radiology, Nuclear Medicine & Medical Imaging
(23)
Aged, 80 And Over
(22)
Neoplasm Staging
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The clinical relevance of a chemo response assay for treatment of epithelial ovarian cancer

Significant delay in the treatment of endometrial cancer based on race and insurance status

A phase II evaluation of AZD6244, a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group (GOG) study

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study

Controversies associated with cervical cytologic screening: a physician's view

An α-Fetoprotein-Producing Hepatoid Adenocarcinoma of the Endometrium

Intraperitoneal administration of alpha-emitting isotopes

Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies

Uterine carcinosarcoma: Immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets

Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy

Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies

Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors

Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies

Synchronous ovarian and endometrial malignancies

Outcome and patterns of failure in pathologic stages I–IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy

Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

Initial Clinical Experience with Intensity-Modulated Whole-Pelvis Radiation Therapy in Women with Gynecologic Malignancies

Radionuclide Therapy for the Treatment of Microscopic Ovarian Carcinoma: An Overview

Rectovaginal radiation fistula repair using an obturator fasciocutaneous thigh flap

Phase II trial of imatinib mesylate (I) in combination with docetaxel (D) in the treatment of patients (pts) with recurrent or persistent epithelial ovarian carcinoma (EOC)

Outcome and pattern of failure in pathologic stage I–II papillary serous carcinoma of the endometrium: Implications for adjuvant radiation therapy

Activity of docetaxel plus trabectedin in recurrent or persistent ovarian and primary peritoneal cancer: A phase II study of the Gynecologic Oncology Group (GOG)

In vitro and in vivo studies on the development of the α-emitting radionuclide bismuth 212 for intraperitoneal use against microscopic ovarian carcinoma

Suchergebnisse filtern